VOYA Investment Management’s Lineage Cell Therapeutics LCTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-38,835
| Closed | -$17.5K | – | 2701 |
|
|
2025
Q1 | $17.5K | Hold |
38,835
| – | – | ﹤0.01% | 2629 |
|
|
2024
Q4 | $19.5K | Sell |
38,835
-17,951
| -32% | -$9.02K | ﹤0.01% | 2729 |
|
|
2024
Q3 | $51.4K | Hold |
56,786
| – | – | ﹤0.01% | 2771 |
|
|
2024
Q2 | $56.6K | Buy |
56,786
+8,956
| +19% | +$8.93K | ﹤0.01% | 2780 |
|
|
2024
Q1 | $70.8K | Sell |
47,830
-8,765
| -15% | -$13K | ﹤0.01% | 2685 |
|
|
2023
Q4 | $61.7K | Hold |
56,595
| – | – | ﹤0.01% | 2830 |
|
|
2023
Q3 | $66.8K | Hold |
56,595
| – | – | ﹤0.01% | 2817 |
|
|
2023
Q2 | $79.8K | Buy |
+56,595
| New | +$79.8K | ﹤0.01% | 2845 |
|
|
2022
Q2 | – | Sell |
-47,315
| Closed | -$73K | – | 2839 |
|
|
2022
Q1 | $73K | Hold |
47,315
| – | – | ﹤0.01% | 2555 |
|
|
2021
Q4 | $116K | Sell |
47,315
-655
| -1% | -$1.61K | ﹤0.01% | 2644 |
|
|
2021
Q3 | $121K | Hold |
47,970
| – | – | ﹤0.01% | 2699 |
|
|
2021
Q2 | $137K | Buy |
+47,970
| New | +$137K | ﹤0.01% | 2699 |
|
|
2020
Q2 | – | Sell |
-59,324
| Closed | -$49K | – | 2561 |
|
|
2020
Q1 | $49K | Sell |
59,324
-12,401
| -17% | -$10.2K | ﹤0.01% | 2493 |
|
|
2019
Q4 | $64K | Buy |
71,725
+25,491
| +55% | +$22.7K | ﹤0.01% | 2620 |
|
|
2019
Q3 | $45K | Hold |
46,234
| – | – | ﹤0.01% | 2513 |
|
|
2019
Q2 | $51K | Hold |
46,234
| – | – | ﹤0.01% | 2562 |
|
|
2019
Q1 | $61K | Buy |
46,234
+13,738
| +42% | +$18.1K | ﹤0.01% | 2497 |
|
|
2018
Q4 | $30K | Hold |
32,496
| – | – | ﹤0.01% | 2526 |
|
|
2018
Q3 | $76K | Hold |
32,496
| – | – | ﹤0.01% | 2530 |
|
|
2018
Q2 | $67K | Hold |
32,496
| – | – | ﹤0.01% | 2580 |
|
|
2018
Q1 | $87K | Hold |
32,496
| – | – | ﹤0.01% | 2496 |
|
|
2017
Q4 | $70K | Hold |
32,496
| – | – | ﹤0.01% | 2546 |
|
|
2017
Q3 | $92K | Hold |
32,496
| – | – | ﹤0.01% | 2556 |
|
|
2017
Q2 | $102K | Buy |
32,496
+8,996
| +38% | +$28.2K | ﹤0.01% | 2564 |
|
|
2017
Q1 | $81K | Buy |
+23,500
| New | +$81K | ﹤0.01% | 2452 |
|